Mirati therapeutics, inc. (MRTX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
ASSETS
Current assets
Cash and cash equivalents

204,505

46,535

91,904

252,092

74,605

32,694

116,710

105,963

20,567

107,703

20,784

19,955

29,757

22,383

19,802

24,542

34,555

49,493

109,881

13,379

14,307

6,593

4,915

8,515

8,317

14,235

7,616

9,740

18,403

Short-term investments

490,855

368,515

362,308

233,435

226,380

190,096

125,902

154,221

128,085

43,134

54,178

67,883

75,703

34,351

53,180

66,771

73,114

72,834

28,132

45,498

53,716

22,710

32,792

38,902

45,058

47,835

-

10,516

18,580

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,418

-

-

Restricted cash equivalents and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

291

285

-

Interest and other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

186

108

-

Other current assets

9,456

9,357

10,436

10,183

5,397

3,870

3,486

3,412

4,421

4,922

4,439

4,439

2,465

2,821

2,504

1,726

2,232

3,075

3,025

2,016

3,166

3,354

2,638

1,744

2,662

2,145

1,510

1,787

2,346

Total current assets

704,816

424,407

464,648

495,710

306,382

226,660

246,098

263,596

153,073

155,759

79,401

92,277

107,925

59,555

75,486

93,039

109,901

125,402

141,038

60,893

71,189

32,657

40,345

49,161

56,037

64,215

17,021

22,436

39,329

Security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

99

101

-

Restricted cash equivalents and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

80

78

-

Deferred costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

374

-

-

Property and equipment, net

2,283

1,776

536

443

429

473

429

445

484

525

571

618

638

629

537

558

601

614

639

693

667

496

524

479

275

322

427

425

333

Other long-term assets

6,348

6,017

5,514

5,303

2,550

1,321

1,166

1,146

987

962

2,089

2,089

2,202

3,260

3,135

2,396

2,001

2,001

2,001

288

326

326

440

24

-

0

-

-

139

Total assets

713,447

432,200

470,698

501,456

309,361

228,454

247,693

265,187

154,544

157,246

82,061

94,984

110,765

63,444

79,158

95,993

112,503

128,017

143,678

61,874

72,182

33,479

41,309

49,664

56,312

64,537

18,001

23,040

39,801

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued liabilities

55,450

48,082

34,689

27,685

24,465

25,775

21,502

17,811

15,761

13,644

13,580

11,737

11,282

15,002

13,661

13,790

10,816

9,798

9,769

7,096

5,111

5,396

5,404

5,915

3,983

5,245

6,555

4,516

5,340

Deferred revenue and other current liabilities

597

824

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue and other current liabilities

-

-

647

529

638

371

439

318

249

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of other liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

68

-

Share-based compensation liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,144

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

167

38,924

38,736

33,407

32,803

12,208

0

Total current liabilities

56,047

48,906

35,336

28,214

25,103

26,146

21,941

18,129

16,010

13,644

13,580

11,737

11,282

15,002

13,661

13,790

10,816

9,798

9,769

7,096

5,111

5,396

-

-

-

38,652

41,562

16,792

5,340

Deferred revenue and other liabilities

1,200

1,000

900

800

704

700

663

714

400

314

-

-

-

133

-

-

-

43

-

-

-

21

-

-

-

0

-

11

45

Other liability

-

-

-

-

-

-

-

-

693

-

329

280

367

-

13

24

34

-

52

58

20

-

-

-

-

-

-

-

-

Total liabilities

57,221

49,905

36,209

28,975

25,807

26,878

22,604

18,843

16,703

13,958

13,909

12,017

11,649

15,135

13,674

13,814

10,850

9,841

9,821

7,154

5,131

5,417

5,571

44,839

42,719

38,652

41,562

16,803

5,385

Commitments and contingencies (see Note 11)

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Shareholders’ equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding at both March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value; 100,000,000 shares authorized; 43,552,312 and 39,517,329 issued and outstanding at March 31, 2020 and December 31, 2019, respectively

44

40

39

39

36

33

33

32

29

29

25

25

25

20

20

20

20

19

19

16

16

14

14

14

13

13

10

10

10

Warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,153

Additional paid-in capital

1,505,431

1,144,667

1,124,484

1,108,306

873,838

751,109

746,385

740,172

603,957

594,407

501,346

499,824

497,531

428,507

425,909

423,149

420,595

415,232

412,535

314,664

311,539

260,616

257,898

218,357

216,111

214,756

154,069

154,469

154,224

Accumulated other comprehensive income

9,707

9,889

9,891

9,788

9,637

9,479

9,444

9,345

9,191

9,479

9,514

9,501

9,604

9,533

9,584

9,618

9,585

9,558

9,519

9,515

9,525

9,521

9,528

9,539

9,516

9,507

9,520

9,520

9,520

Accumulated deficit

-858,956

-772,301

-699,925

-645,652

-599,957

-559,045

-530,773

-503,205

-475,336

-460,627

-442,733

-426,383

-408,044

-389,751

-370,029

-350,608

-328,547

-306,633

-288,216

-269,475

-254,029

-242,089

-231,702

-223,085

-212,047

-198,391

-187,160

-157,762

-140,491

Total shareholders’ equity

656,226

382,295

434,489

472,481

283,554

201,576

225,089

246,344

137,841

143,288

68,152

82,967

99,116

48,309

65,484

82,179

101,653

118,176

133,857

54,720

67,051

28,062

35,738

4,825

13,593

25,885

-23,561

6,237

34,416

Total liabilities and shareholders’ equity

713,447

432,200

470,698

501,456

309,361

228,454

247,693

265,187

154,544

157,246

82,061

94,984

110,765

63,444

79,158

95,993

112,503

128,017

143,678

61,874

72,182

33,479

41,309

49,664

56,312

64,537

18,001

23,040

39,801